arrow_back Back to App

Improved Access to Non-Opioid Pain Treatments in Hospitals

This act aims to improve access to non-opioid pain treatments in hospital outpatient and ambulatory surgical settings, potentially helping to combat the opioid crisis. Citizens will have a wider range of non-addictive pain management options, with Medicare providing separate payments for these treatments. Additionally, the act mandates a report on barriers to other pain therapies, which could lead to future improvements.
Key points
Separate Medicare payments for non-opioid drugs and medical devices for pain treatment in hospital outpatient settings from 2022 to 2027.
Similar separate payments for non-opioid pain treatments in ambulatory surgical centers during the same period.
Report to Congress on barriers to access for other pain therapies (e.g., behavioral, complementary) under Medicare, excluding non-opioid drugs and devices.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_586
Sponsor: Sen. Capito, Shelley Moore [R-WV]
Process start date: 2021-03-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NOPAIN Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_586.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-03-04.

What are the main provisions?

Key points include:

  • Separate Medicare payments for non-opioid drugs and medical devices for pain treatment in hospital outpatient settings from 2022 to 2027.
  • Similar separate payments for non-opioid pain treatments in ambulatory surgical centers during the same period.
  • Report to Congress on barriers to access for other pain therapies (e.g., behavioral, complementary) under Medicare, excluding non-opioid drugs and devices.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Capito, Shelley Moore [R-WV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health